Cargando…
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152973/ https://www.ncbi.nlm.nih.gov/pubmed/35199505 http://dx.doi.org/10.3324/haematol.2021.280325 |
| _version_ | 1784717753825886208 |
|---|---|
| author | Innocenti, Idanna Reda, Gianluigi Visentin, Andrea Coscia, Marta Motta, Marina Murru, Roberta Moia, Riccardo Gentile, Massimo Pennese, Elsa Quaglia, Francesca Maria Albano, Francesco Cassin, Ramona Deodato, Marina Ielo, Claudia Frustaci, Anna Maria Piciocchi, Alfonso Rughini, Arianna Arena, Valentina Di Sevo, Daniela Tomasso, Annamaria Autore, Francesco Del Poeta, Giovanni Scarfò, Lydia Mauro, Francesca Romana Tedeschi, Alessandra Trentin, Livio Pompili, Maurizio Foà, Robin Ghia, Paolo Cuneo, Antonio Laurenti, Luca |
| author_facet | Innocenti, Idanna Reda, Gianluigi Visentin, Andrea Coscia, Marta Motta, Marina Murru, Roberta Moia, Riccardo Gentile, Massimo Pennese, Elsa Quaglia, Francesca Maria Albano, Francesco Cassin, Ramona Deodato, Marina Ielo, Claudia Frustaci, Anna Maria Piciocchi, Alfonso Rughini, Arianna Arena, Valentina Di Sevo, Daniela Tomasso, Annamaria Autore, Francesco Del Poeta, Giovanni Scarfò, Lydia Mauro, Francesca Romana Tedeschi, Alessandra Trentin, Livio Pompili, Maurizio Foà, Robin Ghia, Paolo Cuneo, Antonio Laurenti, Luca |
| author_sort | Innocenti, Idanna |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9152973 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91529732022-06-13 Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study Innocenti, Idanna Reda, Gianluigi Visentin, Andrea Coscia, Marta Motta, Marina Murru, Roberta Moia, Riccardo Gentile, Massimo Pennese, Elsa Quaglia, Francesca Maria Albano, Francesco Cassin, Ramona Deodato, Marina Ielo, Claudia Frustaci, Anna Maria Piciocchi, Alfonso Rughini, Arianna Arena, Valentina Di Sevo, Daniela Tomasso, Annamaria Autore, Francesco Del Poeta, Giovanni Scarfò, Lydia Mauro, Francesca Romana Tedeschi, Alessandra Trentin, Livio Pompili, Maurizio Foà, Robin Ghia, Paolo Cuneo, Antonio Laurenti, Luca Haematologica Letter to the Editor Fondazione Ferrata Storti 2022-02-24 /pmc/articles/PMC9152973/ /pubmed/35199505 http://dx.doi.org/10.3324/haematol.2021.280325 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Innocenti, Idanna Reda, Gianluigi Visentin, Andrea Coscia, Marta Motta, Marina Murru, Roberta Moia, Riccardo Gentile, Massimo Pennese, Elsa Quaglia, Francesca Maria Albano, Francesco Cassin, Ramona Deodato, Marina Ielo, Claudia Frustaci, Anna Maria Piciocchi, Alfonso Rughini, Arianna Arena, Valentina Di Sevo, Daniela Tomasso, Annamaria Autore, Francesco Del Poeta, Giovanni Scarfò, Lydia Mauro, Francesca Romana Tedeschi, Alessandra Trentin, Livio Pompili, Maurizio Foà, Robin Ghia, Paolo Cuneo, Antonio Laurenti, Luca Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study |
| title | Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study |
| title_full | Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study |
| title_fullStr | Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study |
| title_full_unstemmed | Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study |
| title_short | Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study |
| title_sort | risk of hepatitis b virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. a retrospective multicentric gimema study |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152973/ https://www.ncbi.nlm.nih.gov/pubmed/35199505 http://dx.doi.org/10.3324/haematol.2021.280325 |
| work_keys_str_mv | AT innocentiidanna riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT redagianluigi riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT visentinandrea riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT cosciamarta riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT mottamarina riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT murruroberta riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT moiariccardo riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT gentilemassimo riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT penneseelsa riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT quagliafrancescamaria riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT albanofrancesco riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT cassinramona riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT deodatomarina riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT ieloclaudia riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT frustaciannamaria riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT piciocchialfonso riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT rughiniarianna riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT arenavalentina riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT disevodaniela riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT tomassoannamaria riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT autorefrancesco riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT delpoetagiovanni riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT scarfolydia riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT maurofrancescaromana riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT tedeschialessandra riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT trentinlivio riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT pompilimaurizio riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT foarobin riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT ghiapaolo riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT cuneoantonio riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy AT laurentiluca riskofhepatitisbvirusreactivationinchroniclymphocyticleukemiapatientsreceivingibrutinibwithorwithoutantiviralprophylaxisaretrospectivemulticentricgimemastudy |